CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations
暂无分享,去创建一个
S. Ramurthy | S. Subramanian | P. Amiri | J. Dove | B. Levine | Teresa E. Pick | Daniel J. Poon | D. Stuart | A. Harris | Aikawa Mina | Costales Abran | Renhow Paul